ICD-9-CM Volume 2 Index entries containing back-references to
286.53:
- Antibody
- anticardiolipin 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- antiphosphatidylglycerol 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- antiphosphatidylinositol 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- antiphosphatidylserine 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- antiphospholipid 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- Anticoagulant
- lupus (LAC) 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- Circulating anticoagulants, antibodies, or inhibitors (see also Anticoagulants) 286.59
- intrinsic, causing hemorrhagic disorder 286.59
- with
- acquired hemophilia 286.52
- antiphospholipid antibody 286.53
- Disorder - see also Disease
- hemorrhagic NEC 287.9
- due to intrinsic circulating anticoagulants, antibodies, or inhibitors 286.59
- with
- acquired hemophilia 286.52
- antiphospholipid antibody 286.53
- specified type NEC 287.8
- Hemorrhage, hemorrhagic (nontraumatic) 459.0
- disorder 287.9
- due to intrinsic circulating anticoagulants, antibodies, or inhibitors 286.59
- with
- acquired hemophilia 286.52
- antiphospholipid antibody 286.53
- specified type NEC 287.8
- due to
- any device, implant, or graft (presence of) classifiable to 996.0-996.5 - see Complications, due to (presence of) any device, implant, or graft classified to 996.0-996.5 NEC
- intrinsic circulating anticoagulant, antibodies, or inhibitors 286.59
- with
- acquired hemophilia 286.52
- antiphospholipid antibody 286.53
- Inhibitor
- systemic lupus erythematosus (presence of) 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81
- Lupus 710.0
- anticoagulant 795.79
- with
- hemorrhagic disorder 286.53
- hypercoagulable state 289.81